Ben Wolf, partner in Alston & Bird’s Health Care Group, told MobiHealthNews how FDA staffing cuts could slow device approvals and what companies can do to stay ahead.
Q&A: What FDA layoffs mean for medtech approvals
Ben Wolf, partner in Alston & Bird’s Health Care Group, told MobiHealthNews how FDA staffing cuts could slow device approvals and what companies can do to stay ahead.
